413 related articles for article (PubMed ID: 18682503)
21. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
[TBL] [Abstract][Full Text] [Related]
22. Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.
Bry-Gauillard H; Trabado S; Bouligand J; Sarfati J; Francou B; Salenave S; Chanson P; Brailly-Tabard S; Guiochon-Mantel A; Young J
Ann Endocrinol (Paris); 2010 May; 71(3):158-62. PubMed ID: 20363464
[TBL] [Abstract][Full Text] [Related]
23. PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption.
Reynaud R; Jayakody SA; Monnier C; Saveanu A; Bouligand J; Guedj AM; Simonin G; Lecomte P; Barlier A; Rondard P; Martinez-Barbera JP; Guiochon-Mantel A; Brue T
J Clin Endocrinol Metab; 2012 Jun; 97(6):E1068-73. PubMed ID: 22466334
[TBL] [Abstract][Full Text] [Related]
24. The PROK2/PROKR2 signaling pathway is required for the migration of most olfactory bulb interneurons.
Wen Y; Zhang Z; Li Z; Liu G; Tao G; Song X; Xu Z; Shang Z; Guo T; Su Z; Chen H; You Y; Li J; Yang Z
J Comp Neurol; 2019 Dec; 527(18):2931-2947. PubMed ID: 31132148
[TBL] [Abstract][Full Text] [Related]
25. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
[TBL] [Abstract][Full Text] [Related]
26. Kallmann syndrome.
Dodé C; Hardelin JP
Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
[TBL] [Abstract][Full Text] [Related]
27. Kallmann syndrome with a Tyr113His PROKR2 mutation.
Ha JH; Lee S; Kim Y; Moon JI; Seo J; Jang JH; Cho EH; Kim JM; Rhee BD; Ko KS; Yoo SJ; Won JC
Medicine (Baltimore); 2017 Sep; 96(35):e7974. PubMed ID: 28858133
[TBL] [Abstract][Full Text] [Related]
28. Isolated cryptorchidism: no evidence for involvement of genes underlying isolated hypogonadotropic hypogonadism.
Laitinen EM; Tommiska J; Virtanen HE; Oehlandt H; Koivu R; Vaaralahti K; Toppari J; Raivio T
Mol Cell Endocrinol; 2011 Jul; 341(1-2):35-8. PubMed ID: 21664240
[TBL] [Abstract][Full Text] [Related]
29. Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations.
Sbai O; Monnier C; Dodé C; Pin JP; Hardelin JP; Rondard P
FASEB J; 2014 Aug; 28(8):3734-44. PubMed ID: 24830383
[TBL] [Abstract][Full Text] [Related]
30. Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways.
Libri DV; Kleinau G; Vezzoli V; Busnelli M; Guizzardi F; Sinisi AA; Pincelli AI; Mancini A; Russo G; Beck-Peccoz P; Loche S; Crivellaro C; Maghnie M; Krausz C; Persani L; Bonomi M;
J Clin Endocrinol Metab; 2014 Mar; 99(3):E458-63. PubMed ID: 24276467
[TBL] [Abstract][Full Text] [Related]
31. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
[TBL] [Abstract][Full Text] [Related]
32. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism.
Bianco SD; Kaiser UB
Nat Rev Endocrinol; 2009 Oct; 5(10):569-76. PubMed ID: 19707180
[TBL] [Abstract][Full Text] [Related]
33. Clinical genetics of Kallmann syndrome.
Dodé C; Hardelin JP
Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
[TBL] [Abstract][Full Text] [Related]
34. Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.
Sinisi AA; Asci R; Bellastella G; Maione L; Esposito D; Elefante A; De Bellis A; Bellastella A; Iolascon A
Hum Reprod; 2008 Oct; 23(10):2380-4. PubMed ID: 18596028
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic and genotypic landscape of PROKR2 in neuroendocrine disorders.
Martinez-Mayer J; Perez-Millan MI
Front Endocrinol (Lausanne); 2023; 14():1132787. PubMed ID: 36843573
[TBL] [Abstract][Full Text] [Related]
36. Genetic insights into human isolated gonadotropin deficiency.
Trarbach EB; Silveira LG; Latronico AC
Pituitary; 2007; 10(4):381-91. PubMed ID: 17624596
[TBL] [Abstract][Full Text] [Related]
37. Kallmann syndrome in women: from genes to diagnosis and treatment.
Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
[TBL] [Abstract][Full Text] [Related]
38. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
[TBL] [Abstract][Full Text] [Related]
39. [Kallmann syndrome: a historical [corrected] clinical and molecular review].
Ribeiro RS; Abucham J
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):8-17. PubMed ID: 18345392
[TBL] [Abstract][Full Text] [Related]
40. Additional mutation in
Ichioka K; Yoshikawa T; Kimura H; Saito R
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]